Guangdong Transtek Medical Electronics Co Ltd (300562) — Net Asset Quality Index
Guangdong Transtek Medical Electronics Co Ltd (300562) has a Net Asset Quality Index of 69.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.42 Billion minus total liabilities of CN¥427.31 Million yields net assets of CN¥992.41 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Guangdong Transtek Medical Electronics C fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Guangdong Transtek Medical Electronics Co Ltd Net Asset Quality Index Over Time (2011–2024)
This chart shows how Guangdong Transtek Medical Electronics Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 69.9%, representing net assets of CN¥992.41 Million against total assets of CN¥1.42 Billion CNY. Explore Guangdong Transtek Medical Electronics C (300562) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Guangdong Transtek Medical Electronics Co Ltd (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Guangdong Transtek Medical Electronics Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300562 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 64.6% | CN¥976.51 Million | CN¥1.51 Billion | CN¥536.25 Million | ▼ -1.2 pp |
| 2023 | 65.8% | CN¥1.02 Billion | CN¥1.56 Billion | CN¥532.35 Million | ▲ +1.2 pp |
| 2022 | 64.6% | CN¥998.78 Million | CN¥1.55 Billion | CN¥548.46 Million | ▲ +6.2 pp |
| 2021 | 58.4% | CN¥1.05 Billion | CN¥1.79 Billion | CN¥747.10 Million | ▲ +11.0 pp |
| 2020 | 47.4% | CN¥655.01 Million | CN¥1.38 Billion | CN¥728.05 Million | ▼ -10.5 pp |
| 2019 | 57.9% | CN¥568.05 Million | CN¥981.63 Million | CN¥413.58 Million | ▼ -2.7 pp |
| 2018 | 60.6% | CN¥531.97 Million | CN¥878.51 Million | CN¥346.54 Million | ▼ -7.6 pp |
| 2017 | 68.1% | CN¥514.28 Million | CN¥754.90 Million | CN¥240.62 Million | ▼ -8.3 pp |
| 2016 | 76.4% | CN¥506.16 Million | CN¥662.10 Million | CN¥155.94 Million | ▲ +10.7 pp |
| 2015 | 65.7% | CN¥224.63 Million | CN¥341.72 Million | CN¥117.09 Million | ▲ +1.1 pp |
| 2014 | 64.7% | CN¥188.74 Million | CN¥291.93 Million | CN¥103.19 Million | ▲ +8.9 pp |
| 2013 | 55.8% | CN¥122.26 Million | CN¥219.29 Million | CN¥97.03 Million | ▼ -1.5 pp |
| 2012 | 57.3% | CN¥91.56 Million | CN¥159.82 Million | CN¥68.26 Million | ▲ +3.3 pp |
| 2011 | 54.0% | CN¥62.90 Million | CN¥116.49 Million | CN¥53.59 Million | — |